Saudi Chemical Holding Co. reported a net profit of SAR 83.6 million for the first nine months of 2019, a 14.4 percent year-on-year decline.
Item | 9m 2018 | 9m 2019 | Change |
---|---|---|---|
Revenues | 2,075.76 | 2,353.20 | 13.4 % |
Gross Income | 299.30 | 359.73 | 20.2 % |
Operating Income | 138.09 | 142.27 | 3.0 % |
Net Income | 97.75 | 83.60 | (14.5 %) |
Average Shares | 843.20 | 843.20 | - |
EPS (Riyals) | 0.12 | 0.10 | (14.5 %) |
The decline is attributed to launching commercial production of two production lines of AJA's plant (subsidiary company) and charging all costs to income statement for the period. The costs are expected to be covered gradually through the increase in sales.
The company also cited other reasons for the net profit decline including the increase in operational expenses, mainly relating to pharmaceutical sector due to the increase in sales of distributing medicines, as well as higher finance costs and zakat provision.
The company reported a net profit of SAR 13.4 million for Q3 2019, a 0.74 percent year-on-year drop.
When compared to the previous quarter, net profit fell 56.6 percent due to lower sales and higher provision for doubtful debts, finance costs and zakat provision.
Item | Q3 2018 | Q3 2019 | Change |
---|---|---|---|
Revenues | 630.81 | 737.05 | 16.8 % |
Gross Income | 84.18 | 113.62 | 35.0 % |
Operating Income | 28.04 | 35.53 | 26.7 % |
Net Income | 13.51 | 13.40 | (0.8 %) |
Average Shares | 843.20 | 843.20 | - |
EPS (Riyals) | 0.02 | 0.02 | (0.8 %) |
Item | Q2 2019 | Q3 2019 | Change |
---|---|---|---|
Revenues | 775.99 | 737.05 | (5.0 %) |
Gross Income | 120.75 | 113.62 | (5.9 %) |
Operating Income | 49.31 | 35.53 | (28.0 %) |
Net Income | 30.89 | 13.40 | (56.6 %) |
Average Shares | 843.20 | 843.20 | - |
EPS (Riyals) | 0.04 | 0.02 | (56.6 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2010 | 404.20 | (4.4 %) | 98.12 | 13.5 % | 81.77 | 22.3 % |
Q2 2010 | 435.49 | 9.9 % | 106.98 | 24.0 % | 93.46 | 26.6 % |
Q3 2010 | 279.73 | (20.2 %) | 84.51 | 12.5 % | 57.82 | (8.9 %) |
Q4 2010 | 538.90 | 13.8 % | 111.94 | 13.7 % | 81.77 | 9.3 % |
2010 | 1,658.32 | 0.9 % | 425.26 | 22.8 % | 315.91 | 13.2 % |
Q1 2011 | 469.13 | 16.1 % | 127.36 | 29.8 % | 91.51 | 11.9 % |
Q2 2011 | 364.79 | (16.2 %) | 114.09 | 6.6 % | 84.59 | (9.5 %) |
Q3 2011 | 412.74 | 47.5 % | 86.14 | 1.9 % | 54.23 | (6.2 %) |
Q4 2011 | 620.91 | 15.2 % | 105.82 | (5.5 %) | 69.15 | (15.4 %) |
2011 | 1,867.57 | 12.6 % | 433.41 | 1.9 % | 299.48 | (5.2 %) |
Q1 2012 | 543.96 | 16.0 % | 125.43 | (1.5 %) | 93.90 | 2.6 % |
Q2 2012 | 464.55 | 27.3 % | 132.00 | 15.7 % | 94.96 | 12.3 % |
Q3 2012 | 339.73 | (17.7 %) | 96.82 | 12.4 % | 61.57 | 13.5 % |
Q4 2012 | 653.09 | 5.2 % | 120.26 | 13.6 % | 72.51 | 4.9 % |
2012 | 2,001.33 | 7.2 % | 474.51 | 9.5 % | 322.94 | 7.8 % |
Q1 2013 | 608.71 | 11.9 % | 118.07 | (5.9 %) | 79.70 | (15.1 %) |
Q2 2013 | 561.58 | 20.9 % | 131.45 | (0.4 %) | 89.00 | (6.3 %) |
Q3 2013 | 412.44 | 21.4 % | 103.64 | 7.0 % | 66.11 | 7.4 % |
Q4 2013 | 692.39 | 6.0 % | 130.62 | 8.6 % | 80.86 | 11.5 % |
2013 | 2,275.12 | 13.7 % | 479.48 | 1.0 % | 315.47 | (2.3 %) |
Q1 2014 | 693.05 | 13.9 % | 145.19 | 23.0 % | 100.13 | 25.6 % |
Q2 2014 | 651.85 | 16.1 % | 138.73 | 5.5 % | 93.65 | 5.2 % |
Q3 2014 | 529.03 | 28.3 % | 99.05 | (4.4 %) | 48.67 | (26.4 %) |
Q4 2014 | 610.38 | (11.8 %) | 119.82 | (8.3 %) | 72.06 | (10.9 %) |
2014 | 2,484.32 | 9.2 % | 502.80 | 4.9 % | 314.50 | (0.3 %) |
Q1 2015 | 678.47 | (2.1 %) | 139.29 | (4.1 %) | 93.21 | (6.9 %) |
Q2 2015 | 636.15 | (2.4 %) | 141.08 | 1.7 % | 87.33 | (6.7 %) |
Q3 2015 | 489.68 | (7.4 %) | 85.74 | (13.4 %) | 41.49 | (14.8 %) |
Q4 2015 | 607.57 | (0.5 %) | 128.97 | 7.6 % | 63.13 | (12.4 %) |
2015 | 2,409.77 | (3.0 %) | 492.99 | (1.9 %) | 283.07 | (10.0 %) |
Q1 2016 | 588.45 | (13.3 %) | 111.67 | (19.8 %) | 62.63 | (32.8 %) |
Q2 2016 | 617.59 | (2.9 %) | 114.15 | (19.1 %) | 60.50 | (30.7 %) |
Q3 2016 | 444.82 | (9.2 %) | 75.31 | (12.2 %) | 29.12 | (29.8 %) |
Q4 2016 | 492.21 | (19.0 %) | 86.44 | (33.0 %) | 41.73 | (33.9 %) |
2016 | 2,143.06 | (11.1 %) | 387.57 | (21.4 %) | 193.98 | (31.5 %) |
Q1 2017 | 724.68 | 23.2 % | 118.40 | 6.0 % | 66.40 | 6.0 % |
Q2 2017 | 544.28 | (11.9 %) | 93.09 | (18.5 %) | 40.00 | (33.9 %) |
Q3 2017 | 513.16 | 15.4 % | 83.60 | 11.0 % | 37.06 | 27.3 % |
Q4 2017 | 692.22 | 40.6 % | 101.23 | 17.1 % | 44.10 | 5.7 % |
2017 | 2,474.34 | 15.5 % | 396.31 | 2.3 % | 187.55 | (3.3 %) |
Q1 2018 | 791.18 | 9.2 % | 121.48 | 2.6 % | 71.27 | 7.3 % |
Q2 2018 | 653.78 | 20.1 % | 93.63 | 0.6 % | 38.79 | (3.0 %) |
Q3 2018 | 630.81 | 22.9 % | 84.18 | 0.7 % | 28.04 | (24.3 %) |
Q4 2018 | 872.77 | 26.1 % | 111.15 | 9.8 % | 45.84 | 4.0 % |
2018 | 2,948.53 | 19.2 % | 410.44 | 3.6 % | 183.94 | (1.9 %) |
Q1 2019 | 840.16 | 6.2 % | 125.36 | 3.2 % | 57.43 | (19.4 %) |
Q2 2019 | 775.99 | 18.7 % | 120.75 | 29.0 % | 49.31 | 27.1 % |
Q3 2019 | 737.05 | 16.8 % | 113.62 | 35.0 % | 35.53 | 26.7 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2009 | 1,643.34 | 6.9 % | 346.29 | 30.3 % | 278.97 | 30.1 % |
2010 | 1,658.32 | 0.9 % | 425.26 | 22.8 % | 315.91 | 13.2 % |
2011 | 1,867.57 | 12.6 % | 433.41 | 1.9 % | 299.48 | (5.2 %) |
2012 | 2,001.33 | 7.2 % | 474.51 | 9.5 % | 322.94 | 7.8 % |
2013 | 2,275.12 | 13.7 % | 479.48 | 1.0 % | 315.47 | (2.3 %) |
2014 | 2,484.32 | 9.2 % | 502.80 | 4.9 % | 314.50 | (0.3 %) |
2015 | 2,409.77 | (3.0 %) | 492.99 | (1.9 %) | 283.07 | (10.0 %) |
2016 | 2,143.06 | (11.1 %) | 387.57 | (21.4 %) | 193.98 | (31.5 %) |
2017 | 2,474.34 | 15.5 % | 396.31 | 2.3 % | 187.55 | (3.3 %) |
2018 | 2,948.53 | 19.2 % | 410.44 | 3.6 % | 183.94 | (1.9 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2010 | 74.73 | 10.7 % | 0.09 | - | 74.73 | 0.09 |
Q2 2010 | 86.47 | 35.6 % | 0.10 | - | 86.47 | 0.10 |
Q3 2010 | 54.21 | (48.2 %) | 0.06 | - | 53.11 | 0.06 |
Q4 2010 | 87.77 | 34.8 % | 0.10 | - | 87.77 | 0.10 |
2010 | 303.17 | 0.7 % | 0.36 | - | 303.17 | 0.36 |
Q1 2011 | 86.18 | 15.3 % | 0.10 | - | 86.18 | 0.10 |
Q2 2011 | 76.03 | (12.1 %) | 0.09 | - | 76.03 | 0.09 |
Q3 2011 | 46.73 | (13.8 %) | 0.06 | - | 46.73 | 0.06 |
Q4 2011 | 58.46 | (33.4 %) | 0.07 | - | 58.46 | 0.07 |
2011 | 267.41 | (11.8 %) | 0.32 | - | 267.41 | 0.32 |
Q1 2012 | 87.87 | 2.0 % | 0.10 | - | 87.87 | 0.10 |
Q2 2012 | 86.89 | 14.3 % | 0.10 | - | 86.89 | 0.10 |
Q3 2012 | 50.74 | 8.6 % | 0.06 | - | 50.74 | 0.06 |
Q4 2012 | 65.77 | 12.5 % | 0.08 | - | 65.77 | 0.08 |
2012 | 291.27 | 8.9 % | 0.35 | - | 291.27 | 0.35 |
Q1 2013 | 88.29 | 0.5 % | 0.10 | 15.43 | 72.86 | 0.09 |
Q2 2013 | 77.19 | (11.2 %) | 0.09 | 0.08 | 77.12 | 0.09 |
Q3 2013 | 60.38 | 19.0 % | 0.07 | - | 60.38 | 0.07 |
Q4 2013 | 74.75 | 13.6 % | 0.09 | - | 74.75 | 0.09 |
2013 | 300.60 | 3.2 % | 0.36 | 15.51 | 285.09 | 0.34 |
Q1 2014 | 90.95 | 3.0 % | 0.11 | - | 90.95 | 0.11 |
Q2 2014 | 86.64 | 12.2 % | 0.10 | 2.06 | 84.58 | 0.10 |
Q3 2014 | 39.51 | (34.6 %) | 0.05 | - | 39.51 | 0.05 |
Q4 2014 | 66.46 | (11.1 %) | 0.08 | - | 66.46 | 0.08 |
2014 | 283.56 | (5.7 %) | 0.34 | 2.09 | 281.47 | 0.33 |
Q1 2015 | 86.22 | (5.2 %) | 0.10 | - | 86.22 | 0.10 |
Q2 2015 | 78.06 | (9.9 %) | 0.09 | - | 78.06 | 0.09 |
Q3 2015 | 35.75 | (9.5 %) | 0.04 | - | 35.75 | 0.04 |
Q4 2015 | 50.66 | (23.8 %) | 0.06 | - | 50.66 | 0.06 |
2015 | 250.68 | (11.6 %) | 0.30 | - | 250.68 | 0.30 |
Q1 2016 | 51.52 | (40.2 %) | 0.06 | - | 51.52 | 0.06 |
Q2 2016 | 47.40 | (39.3 %) | 0.06 | - | 47.40 | 0.06 |
Q3 2016 | 18.42 | (48.5 %) | 0.02 | - | 18.42 | 0.02 |
Q4 2016 | 17.09 | (66.3 %) | 0.02 | (10.34) | 27.43 | 0.03 |
2016 | 134.43 | (46.4 %) | 0.16 | (10.34) | 144.77 | 0.17 |
Q1 2017 | 55.20 | 7.1 % | 0.07 | - | 55.20 | 0.07 |
Q2 2017 | 28.54 | (39.8 %) | 0.03 | - | 28.54 | 0.03 |
Q3 2017 | 27.85 | 51.2 % | 0.03 | - | 27.85 | 0.03 |
Q4 2017 | 30.57 | 78.9 % | 0.04 | - | 30.57 | 0.04 |
2017 | 142.15 | 5.7 % | 0.17 | - | 142.15 | 0.17 |
Q1 2018 | 56.42 | 2.2 % | 0.07 | - | 56.42 | 0.07 |
Q2 2018 | 27.82 | (2.5 %) | 0.03 | - | 27.82 | 0.03 |
Q3 2018 | 13.51 | (51.5 %) | 0.02 | - | 13.51 | 0.02 |
Q4 2018 | 17.08 | (44.1 %) | 0.02 | - | 17.08 | 0.02 |
2018 | 114.82 | (19.2 %) | 0.14 | - | 114.82 | 0.14 |
Q1 2019 | 39.30 | (30.3 %) | 0.05 | - | 39.30 | 0.05 |
Q2 2019 | 30.89 | 11.0 % | 0.04 | - | 30.89 | 0.04 |
Q3 2019 | 13.40 | (0.8 %) | 0.02 | - | 13.40 | 0.02 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2009 | 301.03 | 50.1 % | 0.36 | - | 301.03 | 0.36 |
2010 | 303.17 | 0.7 % | 0.36 | - | 303.17 | 0.36 |
2011 | 267.41 | (11.8 %) | 0.32 | - | 267.41 | 0.32 |
2012 | 291.27 | 8.9 % | 0.35 | - | 291.27 | 0.35 |
2013 | 300.60 | 3.2 % | 0.36 | 15.51 | 285.09 | 0.34 |
2014 | 283.56 | (5.7 %) | 0.34 | 2.09 | 281.47 | 0.33 |
2015 | 250.68 | (11.6 %) | 0.30 | - | 250.68 | 0.30 |
2016 | 134.43 | (46.4 %) | 0.16 | (10.34) | 144.77 | 0.17 |
2017 | 142.15 | 5.7 % | 0.17 | - | 142.15 | 0.17 |
2018 | 114.82 | (19.2 %) | 0.14 | - | 114.82 | 0.14 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 22.03 % | 18.87 % | 18.98 % |
Q2 2010 | 22.76 % | 19.69 % | 19.89 % |
Q3 2010 | 24.36 % | 20.28 % | 17.54 % |
Q4 2010 | 24.21 % | 19.99 % | 18.22 % |
2010 | 25.64 % | 20.06 % | 18.28 % |
Q1 2011 | 25.00 % | 19.85 % | 18.19 % |
Q2 2011 | 26.50 % | 20.18 % | 18.34 % |
Q3 2011 | 24.62 % | 18.50 % | 16.62 % |
Q4 2011 | 23.21 % | 17.03 % | 14.32 % |
2011 | 23.21 % | 17.03 % | 14.32 % |
Q1 2012 | 22.21 % | 16.52 % | 13.85 % |
Q2 2012 | 22.01 % | 16.23 % | 13.71 % |
Q3 2012 | 23.36 % | 17.22 % | 14.42 % |
Q4 2012 | 23.71 % | 17.12 % | 14.55 % |
2012 | 23.71 % | 17.12 % | 14.55 % |
Q1 2013 | 22.61 % | 15.90 % | 13.37 % |
Q2 2013 | 21.57 % | 14.90 % | 12.32 % |
Q3 2013 | 21.17 % | 14.59 % | 12.35 % |
Q4 2013 | 21.26 % | 14.70 % | 12.53 % |
2013 | 21.07 % | 14.69 % | 12.53 % |
Q1 2014 | 21.65 % | 14.94 % | 12.85 % |
Q2 2014 | 21.15 % | 14.60 % | 12.68 % |
Q3 2014 | 20.01 % | 13.27 % | 11.29 % |
Q4 2014 | 20.24 % | 13.37 % | 11.33 % |
2014 | 20.24 % | 13.37 % | 11.33 % |
Q1 2015 | 20.12 % | 13.27 % | 11.21 % |
Q2 2015 | 20.34 % | 13.11 % | 11.01 % |
Q3 2015 | 20.12 % | 13.05 % | 11.04 % |
Q4 2015 | 20.53 % | 12.70 % | 10.39 % |
2015 | 20.46 % | 12.63 % | 10.40 % |
Q1 2016 | 20.13 % | 11.88 % | 9.30 % |
Q2 2016 | 19.13 % | 10.76 % | 8.05 % |
Q3 2016 | 19.04 % | 10.39 % | 7.44 % |
Q4 2016 | 18.08 % | 10.13 % | 6.76 % |
2016 | 18.08 % | 10.13 % | 6.76 % |
Q1 2017 | 17.30 % | 9.71 % | 6.51 % |
Q2 2017 | 16.92 % | 9.17 % | 5.87 % |
Q3 2017 | 16.78 % | 9.17 % | 6.11 % |
Q4 2017 | 16.02 % | 8.52 % | 5.74 % |
2017 | 16.02 % | 8.52 % | 5.74 % |
Q1 2018 | 15.72 % | 8.50 % | 5.64 % |
Q2 2018 | 15.09 % | 8.20 % | 5.38 % |
Q3 2018 | 14.47 % | 7.69 % | 4.64 % |
Q4 2018 | 13.92 % | 7.35 % | 3.89 % |
2018 | 13.92 % | 7.35 % | 3.89 % |
Q1 2019 | 13.82 % | 6.89 % | 3.26 % |
Q2 2019 | 14.15 % | 7.00 % | 3.23 % |
Q3 2019 | 14.60 % | 7.11 % | 3.12 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2009 | 21.07 % | 17.70 % | 18.32 % |
2010 | 25.64 % | 20.06 % | 18.28 % |
2011 | 23.21 % | 17.03 % | 14.32 % |
2012 | 23.71 % | 17.12 % | 14.55 % |
2013 | 21.07 % | 14.69 % | 12.53 % |
2014 | 20.24 % | 13.37 % | 11.33 % |
2015 | 20.46 % | 12.63 % | 10.40 % |
2016 | 18.08 % | 10.13 % | 6.76 % |
2017 | 16.02 % | 8.52 % | 5.74 % |
2018 | 13.92 % | 7.35 % | 3.89 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 24.28 % | 21.14 % | 18.49 % |
Q2 2010 | 24.57 % | 22.48 % | 19.85 % |
Q3 2010 | 30.21 % | 22.16 % | 18.99 % |
Q4 2010 | 20.77 % | 16.00 % | 16.29 % |
Q1 2011 | 27.15 % | 20.47 % | 18.37 % |
Q2 2011 | 31.28 % | 24.46 % | 20.84 % |
Q3 2011 | 20.87 % | 14.27 % | 11.32 % |
Q4 2011 | 17.04 % | 11.91 % | 9.41 % |
Q1 2012 | 23.06 % | 18.16 % | 16.15 % |
Q2 2012 | 28.41 % | 21.49 % | 18.70 % |
Q3 2012 | 28.50 % | 19.58 % | 14.94 % |
Q4 2012 | 18.41 % | 11.85 % | 10.07 % |
Q1 2013 | 19.40 % | 13.92 % | 11.97 % |
Q2 2013 | 23.41 % | 16.66 % | 13.73 % |
Q3 2013 | 25.13 % | 17.12 % | 14.64 % |
Q4 2013 | 18.87 % | 12.36 % | 10.80 % |
Q1 2014 | 20.95 % | 14.83 % | 13.12 % |
Q2 2014 | 21.28 % | 15.15 % | 12.98 % |
Q3 2014 | 18.72 % | 10.12 % | 7.47 % |
Q4 2014 | 19.63 % | 12.64 % | 10.89 % |
Q1 2015 | 20.53 % | 14.51 % | 12.71 % |
Q2 2015 | 22.18 % | 14.55 % | 12.27 % |
Q3 2015 | 17.51 % | 9.58 % | 7.30 % |
Q4 2015 | 21.23 % | 11.27 % | 8.34 % |
Q1 2016 | 18.98 % | 11.55 % | 8.76 % |
Q2 2016 | 18.48 % | 10.44 % | 7.67 % |
Q3 2016 | 16.93 % | 7.59 % | 4.14 % |
Q4 2016 | 17.56 % | 10.33 % | 5.57 % |
Q1 2017 | 16.34 % | 9.97 % | 7.62 % |
Q2 2017 | 17.10 % | 8.34 % | 5.24 % |
Q3 2017 | 16.29 % | 7.83 % | 5.43 % |
Q4 2017 | 14.62 % | 7.66 % | 4.42 % |
Q1 2018 | 15.35 % | 9.78 % | 7.13 % |
Q2 2018 | 14.32 % | 7.14 % | 4.26 % |
Q3 2018 | 13.34 % | 5.69 % | 2.14 % |
Q4 2018 | 12.74 % | 6.50 % | 1.96 % |
Q1 2019 | 14.92 % | 8.00 % | 4.68 % |
Q2 2019 | 15.56 % | 7.54 % | 3.98 % |
Q3 2019 | 15.42 % | 6.36 % | 1.82 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2010 | 843.20 | 0.37 | 0.37 | 1.56 |
Q2 2010 | 843.20 | 0.39 | 0.39 | 1.55 |
Q3 2010 | 843.20 | 0.33 | 0.33 | 1.61 |
Q4 2010 | 843.20 | 0.36 | 0.36 | 1.60 |
Q1 2011 | 843.20 | 0.37 | 0.37 | 1.71 |
Q2 2011 | 843.20 | 0.36 | 0.36 | 1.65 |
Q3 2011 | 843.20 | 0.35 | 0.35 | 1.70 |
Q4 2011 | 843.20 | 0.32 | 0.32 | 1.62 |
Q1 2012 | 843.20 | 0.32 | 0.32 | 1.73 |
Q2 2012 | 843.20 | 0.33 | 0.33 | 1.72 |
Q3 2012 | 843.20 | 0.34 | 0.34 | 1.78 |
Q4 2012 | 843.20 | 0.35 | 0.35 | 1.69 |
Q1 2013 | 843.20 | 0.35 | 0.33 | 1.79 |
Q2 2013 | 843.20 | 0.33 | 0.32 | 1.77 |
Q3 2013 | 843.20 | 0.35 | 0.33 | 1.84 |
Q4 2013 | 843.20 | 0.36 | 0.34 | 1.78 |
Q1 2014 | 843.20 | 0.36 | 0.36 | 1.89 |
Q2 2014 | 843.20 | 0.37 | 0.37 | 1.86 |
Q3 2014 | 843.20 | 0.35 | 0.34 | 1.90 |
Q4 2014 | 843.20 | 0.34 | 0.33 | 1.83 |
Q1 2015 | 843.20 | 0.33 | 0.33 | 1.93 |
Q2 2015 | 843.20 | 0.32 | 0.32 | 1.80 |
Q3 2015 | 843.20 | 0.32 | 0.32 | 1.84 |
Q4 2015 | 843.20 | 0.30 | 0.30 | 1.90 |
Q1 2016 | 843.20 | 0.26 | 0.26 | 1.75 |
Q2 2016 | 843.20 | 0.22 | 0.22 | 1.81 |
Q3 2016 | 843.20 | 0.20 | 0.20 | 1.83 |
Q4 2016 | 843.20 | 0.16 | 0.17 | 1.74 |
Q1 2017 | 843.20 | 0.16 | 0.18 | 1.81 |
Q2 2017 | 843.20 | 0.14 | 0.15 | 1.76 |
Q3 2017 | 843.20 | 0.15 | 0.16 | 1.80 |
Q4 2017 | 843.20 | 0.17 | 0.17 | 1.76 |
Q1 2018 | 843.20 | 0.17 | 0.17 | 1.83 |
Q2 2018 | 843.20 | 0.17 | 0.17 | 1.86 |
Q3 2018 | 843.20 | 0.15 | 0.15 | 1.78 |
Q4 2018 | 843.20 | 0.14 | 0.14 | 1.81 |
Q1 2019 | 843.20 | 0.12 | 0.12 | 1.85 |
Q2 2019 | 843.20 | 0.12 | 0.12 | 1.89 |
Q3 2019 | 843.20 | 0.12 | 0.12 | 1.90 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2009 | 843.20 | 0.36 | 0.36 | 1.47 |
2010 | 843.20 | 0.36 | 0.36 | 1.60 |
2011 | 843.20 | 0.32 | 0.32 | 1.62 |
2012 | 843.20 | 0.35 | 0.35 | 1.69 |
2013 | 843.20 | 0.36 | 0.34 | 1.78 |
2014 | 843.20 | 0.34 | 0.33 | 1.83 |
2015 | 843.20 | 0.30 | 0.30 | 1.90 |
2016 | 843.20 | 0.16 | 0.17 | 1.74 |
2017 | 843.20 | 0.17 | 0.17 | 1.76 |
2018 | 843.20 | 0.14 | 0.14 | 1.81 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2010 | 8.80 | 8.80 | 2.06 |
Q2 2010 | 7.78 | 7.78 | 1.97 |
Q3 2010 | 10.75 | 10.80 | 2.22 |
Q4 2010 | 8.68 | 8.71 | 1.94 |
Q1 2011 | 9.09 | 9.12 | 1.99 |
Q2 2011 | 9.50 | 9.54 | 2.08 |
Q3 2011 | 8.76 | 8.76 | 1.81 |
Q4 2011 | 9.29 | 9.29 | 1.82 |
Q1 2012 | 9.71 | 9.71 | 1.79 |
Q2 2012 | 8.67 | 8.67 | 1.68 |
Q3 2012 | 8.69 | 8.69 | 1.65 |
Q4 2012 | 9.71 | 9.71 | 1.99 |
Q1 2013 | 9.19 | 9.71 | 1.78 |
Q2 2013 | 10.32 | 10.92 | 1.95 |
Q3 2013 | 10.32 | 10.90 | 1.94 |
Q4 2013 | 11.57 | 12.20 | 2.32 |
Q1 2014 | 12.72 | 12.72 | 2.42 |
Q2 2014 | 14.29 | 14.38 | 2.85 |
Q3 2014 | 16.47 | 16.59 | 2.99 |
Q4 2014 | 12.77 | 12.86 | 2.35 |
Q1 2015 | 15.68 | 15.79 | 2.68 |
Q2 2015 | 17.04 | 17.04 | 3.03 |
Q3 2015 | 14.78 | 14.78 | 2.53 |
Q4 2015 | 14.46 | 14.46 | 2.27 |
Q1 2016 | 13.72 | 13.72 | 2.00 |
Q2 2016 | 14.53 | 14.53 | 1.76 |
Q3 2016 | 11.77 | 11.77 | 1.28 |
Q4 2016 | 18.32 | 17.01 | 1.68 |
Q1 2017 | 15.42 | 14.35 | 1.40 |
Q2 2017 | 20.31 | 18.69 | 1.63 |
Q3 2017 | 17.20 | 15.92 | 1.46 |
Q4 2017 | 14.29 | 14.29 | 1.37 |
Q1 2018 | 14.60 | 14.60 | 1.36 |
Q2 2018 | 15.80 | 15.80 | 1.44 |
Q3 2018 | 16.17 | 16.17 | 1.38 |
Q4 2018 | 17.10 | 17.10 | 1.29 |
Q1 2019 | 20.97 | 20.97 | 1.31 |
Q2 2019 | 19.42 | 19.42 | 1.23 |
Q3 2019 | 21.78 | 21.78 | 1.36 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2009 | 8.70 | 8.70 | 2.11 |
2010 | 8.68 | 8.68 | 1.94 |
2011 | 9.29 | 9.29 | 1.82 |
2012 | 9.71 | 9.71 | 1.99 |
2013 | 11.57 | 12.20 | 2.32 |
2014 | 12.77 | 12.86 | 2.35 |
2015 | 14.46 | 14.46 | 2.27 |
2016 | 18.32 | 17.01 | 1.68 |
2017 | 14.29 | 14.29 | 1.37 |
2018 | 17.10 | 17.10 | 1.29 |
Q3 2019
2019
Period | Medicines and medical supplies | Explosives sector | Production of ammonium nitrate |
---|---|---|---|
Q1 2010 | 313.46 | 76.69 | 14.06 |
Q2 2010 | 329.91 | 91.05 | 14.52 |
Q3 2010 | 197.06 | 74.39 | 8.29 |
Q4 2010 | 458.47 | 71.57 | 8.86 |
Q1 2011 | 368.14 | 99.55 | 1.43 |
Q2 2011 | 269.28 | 95.51 | - |
Q3 2011 | 334.61 | 76.50 | 1.63 |
Q4 2011 | 532.27 | 86.84 | 1.81 |
Q1 2012 | 441.68 | 102.29 | - |
Q2 2012 | 347.97 | 115.14 | 1.43 |
Q3 2012 | 249.03 | 90.71 | - |
Q4 2012 | 560.94 | 90.71 | 1.44 |
Q1 2013 | 504.23 | 99.55 | 4.94 |
Q2 2013 | 454.26 | 110.50 | (3.18) |
Q3 2013 | 305.21 | 107.23 | - |
Q4 2013 | 595.40 | 97.00 | - |
Q1 2014 | 577.21 | 115.84 | - |
Q2 2014 | 513.14 | 138.71 | - |
Q3 2014 | 434.89 | 91.56 | 2.58 |
Q4 2014 | 500.81 | 108.14 | 1.44 |
Q1 2015 | 560.46 | 115.12 | 2.89 |
Q2 2015 | 519.48 | 113.30 | 3.37 |
Q3 2015 | 407.09 | 77.87 | 2.63 |
Q4 2015 | 495.40 | 108.75 | 3.42 |
Q1 2016 | 486.51 | 100.15 | 1.79 |
Q2 2016 | 523.71 | 92.30 | 1.58 |
Q3 2016 | 380.20 | 67.99 | - |
Q4 2016 | 401.59 | 84.23 | 6.39 |
Q1 2017 | 642.39 | 81.80 | 0.49 |
Q2 2017 | 461.84 | 80.81 | 1.63 |
Q3 2017 | 439.71 | 69.84 | 3.61 |
Q4 2017 | 601.78 | 86.92 | 3.52 |
Q1 2018 | 709.39 | 79.68 | 2.11 |
Q2 2018 | 593.51 | 58.30 | 1.97 |
Q3 2018 | 574.96 | 48.59 | 7.26 |
Q4 2018 | 802.01 | 64.80 | 5.96 |
Q1 2019 | 763.56 | 66.18 | 10.41 |
Q2 2019 | 710.38 | 61.38 | 4.22 |
Q3 2019 | 672.06 | 62.22 | 2.77 |
Period | Medicines and medical supplies | Explosives sector | Production of ammonium nitrate |
---|---|---|---|
2009 | 1,355.69 | 287.65 | - |
2010 | 1,298.90 | 313.69 | 45.73 |
2011 | 1,504.30 | 358.40 | 4.88 |
2012 | 1,599.61 | 398.85 | 2.87 |
2013 | 1,859.09 | 414.27 | 1.76 |
2014 | 2,026.05 | 454.25 | 4.02 |
2015 | 1,982.43 | 415.03 | 12.31 |
2016 | 1,792.00 | 344.67 | 6.39 |
2017 | 2,145.72 | 319.37 | 9.25 |
2018 | 2,679.85 | 251.37 | 17.31 |
Item | Q3 2019 (e) | Q3 2019 (a) | Change |
---|---|---|---|
Average | 25.60 | 13.40 | (47.6 %) |
Item | Q3 2019 (e) | Q3 2019 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 25.60 | 13.40 | (47.6) % |
Current | |
Market Cap (M Riyal) | 8,634.37 |
Enterprise Value (EV) (M) | 9,797.77 |
Shares Outstanding ((M)) | 843.20 |
EPS ( Riyal) (TTM) | 0.39 |
Book Value (BV) ( Riyal) | 2.42 |
Par Value ( Riyal) | 1.00 |
Adjusted P/E (Last12) | 26.47 |
P/E (TTM) | 26.47 |
Price/book | 4.24 |
Return on Average Assets (%) (TTM) | 5.9 |
Return on Average Equity (%) (TTM) | 17.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}